RBM39 and breast carcinoma: Regarding the regulation of alternative splicing of RBM39, it was further confirmed that in T47D breast cancer cells, downregulated expression of RBM39 could correspondingly change the alternative splicing of vascular endothelial growth factor (VEGF) and increase the ratio of VEGF121 and VEGF189 in breast cancer [14].